Misha Gautam, MBBS
@MishaGautam55
Followers
285
Following
392
Statuses
34
IM PGY2 @umkcIM | Research Fellow @MayoClinicGIHep | MBBS GMCH Chandigarh | Aspiring Gastroenterologist
Joined August 2022
RT @MarkPimentelMD: This is a must read. It is important we get this right for patients. Editorial now pre-press in @AGA_Gastro. @Prof_Nick…
0
9
0
RT @MayoClinicGIHep: 🚨 New insights into gastric emptying (GE) testing for diabetes! 🚨 •13C-Spirulina GEBT now validated for both delayed …
0
2
0
RT @vinayjaha: Strong work by @MishaGautam55, @Meddoc77 and team, describing a case of ICI + CMV colitis, published in @ACGCRJ
https://t.…
0
5
0
RT @BlaneyMD: Excited to share this review in @HepCommJournal on Neuro-GI and motility disorders in cirrhosis (quite common)! @FcoIdalsoa…
0
28
0
RT @umkcIM: Excited to celebrate the outstanding fellowship match results of our UMKC Internal Medicine residents! We’re proud of your achi…
0
12
0
RT @drkeithsiau: There are many reversible causes of bloating but abdominal distension to the point of looking pregnant is often refractory…
0
12
0
RT @jyotroop_k: A meeting to remember 🌊🏝️ Had a great time presenting our work at @apapancreas meeting and catching up with mentors and col…
0
1
0
0
0
2
Grateful to my mentors and seniors for their incredible support and making #ACG2024 a success! Thank you for guiding me every step of the way. Dr. Hassan Ghoz @MdOblizajek Dr. Robert Kraichely @prteja2389 @vinayjaha
#GITwitter @AmCollegeGastro @umkcIM
0
1
40
Thank you to @AmyOxentenkoMD for inspiring this project about coverage restrictions on bowel preps. Grateful to @utkarshgoel08 and @BabuPMohan2 for helping bring it to fruition. ⭐️Medicare Part D mostly allows unrestricted access to bowel preps, but better-tolerated, low-volume options remain on higher cost tiers, likely impacting patient choice. ⭐️Providers need to understand coverage dynamics to guide effective prep decisions. #Advocacy #CRCscreening #ACG2024 #GITwitter @AmCollegeGastro
0
1
17
Grateful to have played a small role in the multi center FIT trial presented at the ACG presidential plenary session. ➡️Biofeedback therapy and dextranomer hyaluronate injection equally efficacious in reducing FI at 3mo. @MayoClinicGIHep @AmCollegeGastro #ACG2024 #GITwitter
0
2
22
#ACG2024!! Reconnected with old friends and met some amazing people. Special shoutout to the Women in GI Luncheon—truly inspiring! #GICommunity #GITwitter #WomenInGI
@john_damianosMD @JosephHabibi_MD @jyotroop_k @DrTasnimAhmed @AmCollegeGastro
0
4
45
RT @umfoodoc: Adil Bharucha presenting our penultimate multicenter NIH sponsored Fecal Incontinence study showing similar outcomes with bio…
0
2
0
RT @umkcIM: Congratulations to our amazing Internal Medicine residents for a fantastic showing at ACP Missouri! Strong representation with…
0
2
0
RT @DDrossman: This upcoming Sunday, join us for the next @RomeFoundation Grand Rounds on low #FODMAP diets to learn more about this treatm…
0
1
0